Retatrutide and trizepatide are a recent class of medications that bind to both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. These dual receptor agonists exhibit https://geraldymjh349871.blogoxo.com/39057703/new-glp-1-and-gip-receptor-agonists-retatrutide-and-trizepatide